176 related articles for article (PubMed ID: 12411763)
1. Behavioural pathology in Alzheimer's disease with special reference to apolipoprotein E genotype.
Gabryelewicz T; Religa D; Styczynska M; Peplonska B; Pfeffer A; Wasiak B; Luczywek E; Golebiowski M; Androsiuk W; Czyzewski K; Przekop I; Barcikowska M
Dement Geriatr Cogn Disord; 2002; 14(4):208-12. PubMed ID: 12411763
[TBL] [Abstract][Full Text] [Related]
2. Depression, delusions, and hallucinations in Alzheimer's disease: no relationship to apolipoprotein E genotype.
Lyketsos CG; Baker L; Warren A; Steele C; Brandt J; Steinberg M; Kopunek S; Baker A
J Neuropsychiatry Clin Neurosci; 1997; 9(1):64-7. PubMed ID: 9017530
[TBL] [Abstract][Full Text] [Related]
3. Dose dependent effect of APOE epsilon4 on behavioral symptoms in frontal lobe dementia.
Engelborghs S; Dermaut B; Mariën P; Symons A; Vloeberghs E; Maertens K; Somers N; Goeman J; Rademakers R; Van den Broeck M; Pickut B; Cruts M; Van Broeckhoven C; De Deyn PP
Neurobiol Aging; 2006 Feb; 27(2):285-92. PubMed ID: 16399213
[TBL] [Abstract][Full Text] [Related]
4. Effect of the apolipoprotein E epsilon4 allele on the efficacy and tolerability of galantamine in the treatment of Alzheimer's disease.
Suh GH; Jung HY; Lee CU; Oh BH; Lee SK; Lee N; Kim J; Kee BS; Ko D; Kim YH; Ju YS; Hong I; Choi S;
Dement Geriatr Cogn Disord; 2006; 21(1):33-9. PubMed ID: 16254428
[TBL] [Abstract][Full Text] [Related]
5. Apolipoprotein E-epsilon4 alleles in cerebral amyloid angiopathy and cerebrovascular pathology associated with Alzheimer's disease.
Premkumar DR; Cohen DL; Hedera P; Friedland RP; Kalaria RN
Am J Pathol; 1996 Jun; 148(6):2083-95. PubMed ID: 8669492
[TBL] [Abstract][Full Text] [Related]
6. Four components describe behavioral symptoms in 1,120 individuals with late-onset Alzheimer's disease.
Hollingworth P; Hamshere ML; Moskvina V; Dowzell K; Moore PJ; Foy C; Archer N; Lynch A; Lovestone S; Brayne C; Rubinsztein DC; Lawlor B; Gill M; Owen MJ; Williams J
J Am Geriatr Soc; 2006 Sep; 54(9):1348-54. PubMed ID: 16970641
[TBL] [Abstract][Full Text] [Related]
7. The Role of Alzheimer's and Cerebrovascular Pathology in Mediating the Effects of Age, Race, and Apolipoprotein E Genotype on Dementia Severity in Pathologically-Confirmed Alzheimer's Disease.
Gavett BE; John SE; Gurnani AS; Bussell CA; Saurman JL
J Alzheimers Dis; 2016; 49(2):531-45. PubMed ID: 26444761
[TBL] [Abstract][Full Text] [Related]
8. ApoE epsilon4 allele is associated with incidental hallucinations and delusions in patients with AD.
Chang JB; Wang PN; Chen WT; Liu CY; Hong CJ; Lin KN; Liu TY; Chi CW; Liu HC
Neurology; 2004 Sep; 63(6):1105-7. PubMed ID: 15452311
[TBL] [Abstract][Full Text] [Related]
9. Apolipoprotein E genotypes and neuropsychiatric symptoms and syndromes in late-onset Alzheimer's disease.
Panza F; Frisardi V; Seripa D; D'Onofrio G; Santamato A; Masullo C; Logroscino G; Solfrizzi V; Pilotto A
Ageing Res Rev; 2012 Jan; 11(1):87-103. PubMed ID: 21763789
[TBL] [Abstract][Full Text] [Related]
10. Lack of effect of apolipoprotein E E4 allele on neuropsychiatric manifestations in Alzheimer's disease.
Hirono N; Mori E; Yasuda M; Imamura T; Shimomura T; Hashimoto M; Tanimukai S; Kazui H; Yamashita H
J Neuropsychiatry Clin Neurosci; 1999; 11(1):66-70. PubMed ID: 9990558
[TBL] [Abstract][Full Text] [Related]
11. Factors associated with psychotic symptoms in Alzheimer's disease.
Hirono N; Mori E; Yasuda M; Ikejiri Y; Imamura T; Shimomura T; Ikeda M; Hashimoto M; Yamashita H
J Neurol Neurosurg Psychiatry; 1998 May; 64(5):648-52. PubMed ID: 9598682
[TBL] [Abstract][Full Text] [Related]
12. Dopamine D3 receptor gene polymorphism influences on behavioral and psychological symptoms of dementia (BPSD) in mild dementia of Alzheimer's type.
Sato N; Ueki A; Ueno H; Shinjo H; Morita Y
J Alzheimers Dis; 2009; 17(2):441-8. PubMed ID: 19363270
[TBL] [Abstract][Full Text] [Related]
13. Delusion symptoms are associated with ApoE epsilon4 allelic variant at the early stage of Alzheimer's disease with late onset.
Spalletta G; Bernardini S; Bellincampi L; Federici G; Trequattrini A; Caltagirone C
Eur J Neurol; 2006 Feb; 13(2):176-82. PubMed ID: 16490049
[TBL] [Abstract][Full Text] [Related]
14. A longitudinal study of apolipoprotein-E genotype and depressive symptoms in community-dwelling older adults.
Mauricio M; O'Hara R; Yesavage JA; Friedman L; Kraemer HC; Van De Water M; Murphy GM
Am J Geriatr Psychiatry; 2000; 8(3):196-200. PubMed ID: 10910416
[TBL] [Abstract][Full Text] [Related]
15. Neuropsychiatric symptoms and Apolipoprotein E: Associations with eventual Alzheimer's disease development.
Burke SL; Maramaldi P; Cadet T; Kukull W
Arch Gerontol Geriatr; 2016; 65():231-8. PubMed ID: 27111252
[TBL] [Abstract][Full Text] [Related]
16. Association Between Psychosis Phenotype and APOE Genotype on the Clinical Profiles of Alzheimer's Disease.
Qian W; Fischer CE; Schweizer TA; Munoz DG
Curr Alzheimer Res; 2018; 15(2):187-194. PubMed ID: 28847281
[TBL] [Abstract][Full Text] [Related]
17. Lack of association between the apolipoprotein E genotype and depression in Alzheimer's disease.
Liu CY; Hong CJ; Liu TY; Lin KN; Wang PN; Chi CW; Chuang YY; Liu HC
J Geriatr Psychiatry Neurol; 2002; 15(1):20-3. PubMed ID: 11936239
[TBL] [Abstract][Full Text] [Related]
18. Apolipoprotein E genotype and the diagnostic accuracy of cerebrospinal fluid biomarkers for Alzheimer disease.
Lautner R; Palmqvist S; Mattsson N; Andreasson U; Wallin A; Pålsson E; Jakobsson J; Herukka SK; Owenius R; Olsson B; Hampel H; Rujescu D; Ewers M; Landén M; Minthon L; Blennow K; Zetterberg H; Hansson O;
JAMA Psychiatry; 2014 Oct; 71(10):1183-91. PubMed ID: 25162367
[TBL] [Abstract][Full Text] [Related]
19. Apolipoprotein E epsilon4 allele differentiates the clinical response to donepezil in Alzheimer's disease.
Bizzarro A; Marra C; Acciarri A; Valenza A; Tiziano FD; Brahe C; Masullo C
Dement Geriatr Cogn Disord; 2005; 20(4):254-61. PubMed ID: 16103669
[TBL] [Abstract][Full Text] [Related]
20. Apolipoprotein E genotype influences presence and severity of delusions and aggressive behavior in Alzheimer disease.
van der Flier WM; Staekenborg S; Pijnenburg YA; Gillissen F; Romkes R; Kok A; Bouwman FH; Scheltens P
Dement Geriatr Cogn Disord; 2007; 23(1):42-6. PubMed ID: 17077632
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
